These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 24751452)

  • 1. Extent of disease activity assessed by 18F-FDG PET/CT in a Dutch sarcoidosis population.
    Cremers JP; Van Kroonenburgh MJ; Mostard RL; Vöö SA; Wijnen PA; Koek GH; Drent M
    Sarcoidosis Vasc Diffuse Lung Dis; 2014 Apr; 31(1):37-45. PubMed ID: 24751452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory activity assessment by F18 FDG-PET/CT in persistent symptomatic sarcoidosis.
    Mostard RL; Vöö S; van Kroonenburgh MJ; Verschakelen JA; Wijnen PA; Nelemans PJ; Erckens RJ; Drent M
    Respir Med; 2011 Dec; 105(12):1917-24. PubMed ID: 21899998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severity of pulmonary involvement and (18)F-FDG PET activity in sarcoidosis.
    Mostard RL; Verschakelen JA; van Kroonenburgh MJ; Nelemans PJ; Wijnen PA; Vöö S; Drent M
    Respir Med; 2013 Mar; 107(3):439-47. PubMed ID: 23261309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. F-18 FDG PET/CT for detecting bone and bone marrow involvement in sarcoidosis patients.
    Mostard RL; Prompers L; Weijers RE; van Kroonenburgh MJ; Wijnen PA; Geusens PP; Drent M
    Clin Nucl Med; 2012 Jan; 37(1):21-5. PubMed ID: 22157023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of 18F-FDG PET/CT for diagnosis and adjustment of therapy in patients with active chronic sarcoidosis.
    Sobic-Saranovic D; Grozdic I; Videnovic-Ivanov J; Vucinic-Mihailovic V; Artiko V; Saranovic D; Djuric-Stefanovic A; Masulovic D; Odalovic S; Ilic-Dudvarski A; Popevic S; Pavlovic S; Obradovic V
    J Nucl Med; 2012 Oct; 53(10):1543-9. PubMed ID: 22879080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responsiveness of FDG PET/CT to treatment of patients with active chronic sarcoidosis.
    Sobic-Saranovic DP; Grozdic IT; Videnovic-Ivanov J; Vucinic-Mihailovic V; Artiko VM; Saranovic DZ; Pavlovic SV; Obradovic VB
    Clin Nucl Med; 2013 Jul; 38(7):516-21. PubMed ID: 23486337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (18)F-FDG PET/CT for the assessment of disease extension and activity in patients with sarcoidosis: results of a preliminary prospective study.
    Ambrosini V; Zompatori M; Fasano L; Nanni C; Nava S; Rubello D; Fanti S
    Clin Nucl Med; 2013 Apr; 38(4):e171-7. PubMed ID: 23429384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI and FDG PET/CT imaging manifestations of cardiac sarcoidosis.
    Lu Y; Sweiss NJ
    Clin Nucl Med; 2015 Dec; 40(12):973-4. PubMed ID: 26544904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular sarcoidosis: does (18)F-FDG PET/CT have any role?
    Jung RS; Mittal BR; Maturu NV; Kumar R; Bhattacharya A; Gupta D
    Clin Nucl Med; 2014 May; 39(5):464-6. PubMed ID: 24662648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis.
    Teirstein AS; Machac J; Almeida O; Lu P; Padilla ML; Iannuzzi MC
    Chest; 2007 Dec; 132(6):1949-53. PubMed ID: 17925421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDG PET/CT in bone sarcoidosis.
    Grozdic Milojevic I; Sobic-Saranovic D; Videnovic-Ivanov J; Saranovic D; Odalovic S; Artiko V
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Mar; 33(1):66-74. PubMed ID: 27055838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of integrated FDG-PET/CT in sarcoidosis.
    Krüger S; Buck AK; Mottaghy FM; Pauls S; Schelzig H; Hombach V; Reske SN
    Clin Imaging; 2008; 32(4):269-73. PubMed ID: 18603181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current clinical use of 18FDG-PET/CT in patients with thoracic and systemic sarcoidosis.
    Rubini G; Cappabianca S; Altini C; Notaristefano A; Fanelli M; Stabile Ianora AA; Niccoli Asabella A; Rotondo A
    Radiol Med; 2014 Jan; 119(1):64-74. PubMed ID: 24234183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting Enzyme as a Predictor of Extrathoracic Involvement of Sarcoidosis.
    Yasar Z; Özgül MA; Cetinkaya E; Kargi A; Gül Ş; Talay F; Tanriverdi E; Dincer HE
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Jan; 32(4):318-24. PubMed ID: 26847099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional imaging in extrapulmonary sarcoidosis: FDG-PET/CT and MR features.
    Soussan M; Augier A; Brillet PY; Weinmann P; Valeyre D
    Clin Nucl Med; 2014 Feb; 39(2):e146-59. PubMed ID: 23579973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of 18F-FDG-PET and PET/CT in patients with sarcoidosis: an updated evidence-based review.
    Treglia G; Annunziata S; Sobic-Saranovic D; Bertagna F; Caldarella C; Giovanella L
    Acad Radiol; 2014 May; 21(5):675-84. PubMed ID: 24703482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis.
    Ohira H; Birnie DH; Pena E; Bernick J; Mc Ardle B; Leung E; Wells GA; Yoshinaga K; Tsujino I; Sato T; Manabe O; Oyama-Manabe N; Nishimura M; Tamaki N; Dick A; Dennie C; Klein R; Renaud J; deKemp RA; Ruddy TD; Chow BJW; Davies R; Hessian R; Liu P; Beanlands RSB; Nery PB
    Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):259-269. PubMed ID: 26359191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hybrid Imaging in Evaluation of Abdominal Sarcoidosis.
    Milojevic IG; Sobic-Saranovic D; Petrovic N; Beatovic S; Tadic M; Artiko VM
    Curr Med Imaging Rev; 2019; 15(1):26-31. PubMed ID: 31964324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of unknown sarcoidosis associated to erythema nodosum with 18F-FDG PET/CT.
    Rampin L; Musto A; Marzola MC; Tadayyon S; Ferretti A; Chondrogiannis S; Grassetto G; Rubello D
    Rev Esp Med Nucl Imagen Mol; 2013; 32(3):190-2. PubMed ID: 23522858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant disease as an incidental finding at ¹⁸F-FDG-PET/CT scanning in patients with granulomatous lung disease.
    Huber H; Hodolic M; Stelzmüller I; Wunn R; Hatzl M; Fellner F; Lamprecht B; Rubello D; Colletti PM; Gabriel M
    Nucl Med Commun; 2015 May; 36(5):430-7. PubMed ID: 25646704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.